Division of Pulmonary and Critical Care Medicine.
Clin Infect Dis. 2013 Nov;57(10):1473-82. doi: 10.1093/cid/cit488. Epub 2013 Jul 29.
Solid organ transplant (SOT) recipients are at risk for opportunistic infections including tuberculosis. Although guidelines on the management of latent tuberculosis and active tuberculosis are available, there remain a number of clinical areas with limited guidance. We discuss challenges in the diagnosis, management, and treatment of latent and active tuberculosis in SOT candidates and recipients who reside in low-tuberculosis-prevalence areas. We discuss the diagnosis of latent tuberculosis in SOT candidates/recipients using tuberculin skin tests and interferon-γ release assays and risk stratification of SOT candidates/recipients that would identify individuals at high risk for latent tuberculosis despite negative test results. Through a careful review of posttransplant tuberculosis cases, we identify a history of treated tuberculosis in SOT recipients as a risk factor for development of posttransplant active tuberculosis. Finally, we include comparisons of recommendations by several large transplant organizations and identify areas for future research.
实体器官移植(SOT)受者存在机会性感染(包括结核病)的风险。尽管有关于潜伏性和活动性结核病管理的指南,但仍有许多临床领域缺乏指导。我们讨论了低结核病流行地区 SOT 候选人和受者潜伏和活动性结核病的诊断、管理和治疗方面的挑战。我们讨论了使用结核菌素皮肤试验和干扰素-γ释放试验诊断 SOT 候选者/受者的潜伏性结核病,以及对 SOT 候选者/受者进行风险分层,以确定尽管检测结果为阴性但仍有潜伏性结核病高风险的个体。通过对移植后结核病病例的仔细回顾,我们发现 SOT 受者既往治疗过的结核病史是发生移植后活动性结核病的危险因素。最后,我们比较了几个大型移植组织的建议,并确定了未来研究的领域。